The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin.
Shukla S, Milewski D, Pradhan A, Rama N, Rice K, Le T, Flick MJ, Vaz S, Zhao X, Setchell KD, Logarinho E, Kalinichenko VV, Kalin TV.
Shukla S, et al. Among authors: logarinho e.
Mol Cancer Ther. 2019 Jul;18(7):1217-1229. doi: 10.1158/1535-7163.MCT-18-0709. Epub 2019 Apr 30.
Mol Cancer Ther. 2019.
PMID: 31040162
Free PMC article.